Find Datasets from
UMB Researchers

mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
UMB Dataset

UID: 189

Author(s): Etsuro Nanishi, Marisa E. McGrath, Timothy R. O’Meara, Soumik Barman, Jingyou Yu, Huahua Wan, Carly A. Dillen, Manisha Menon, Hyuk-Soo Seo, Kijun Song, Andrew Z. Xu, Luke Sebastian, Byron Brook, Anna-Nicole Bosco, Francesco Borriello, Robert K. Ernst, Dan H. Barouch, Sirano Dhe-Paganon, Ofer Levy, Matthew B. Frieman, David J. Dowling* * Corresponding Author
Description
This study investigates multiple vaccine strategies to enhance immunogenicity and protection against SARS-CoV-2 in aged mice. The study aims to determine the effect of a booster dose, with an emphasis on older age. Female three and eleven-month-old BALB/c mice were studied over the course of 38 weeks. Mice received BNT162b2 SARS-CoV-2 spike mRNA vaccine series, primary vaccination series, and mock Phosphate-buffered saline (PBS) injections. Single mouse experiments aimed to include 20 mice per group. Sample size and age criteria were chosen empirically based on the results of previous studies. Mice were randomly assigned to different treatment groups.
Local Experts
Subject of Study
Subject Domain
Subject Sex
Female
Keywords
Access Restrictions
Unrestricted access
Access Instructions
All data supporting the findings of this study are available within the supplementary information files (Supplementary Data 1). The data corresponds to the figures that are in the article.
Associated Publications
Data Type
Equipment Used
BD LSR II Flow Cytometer
Bead ruptor (Omni International Inc.)
UltraPure agarose (Invitrogen)
Software Used
FlowJo v.10.8.1
Study Type
Interventional
Longitudinal
Dataset Format(s)
XLSX
Dataset Size
50 KB
Grant Support
HHSN272201400052C/United States. National Institute of Allergy and Infectious Diseases
75N93019C00044/United States. National Institute of Allergy and Infectious Diseases
HHSN272201800047C/United States. National Institute of Allergy and Infectious Diseases
1R21AI137932-01A1/National Institutes of Health (U.S.)
ASPR-20-01495/Biomedical Advanced Research and Development Authority (U.S.)